Zero Point Five Therapeutics, Inc. — Form D
Zero Point Five Therapeutics, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2023-07-12. The offering totals $10.1M, of which $7.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-07-12
- Form: D
- Accession: 0001985295-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.1M
- Amount sold: $7.2M
- Remaining: $2.9M
- Investors: 15
- Date of first sale: 2023-06-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-486687
Issuer
- Name: Zero Point Five Therapeutics, Inc.
- CIK: 0001985295
- Entity type: Corporation
- Jurisdiction: DISTRICT OF COLUMBIA
- Incorporated: 2018
- Address: 915 S. EATON STREET, BALTIMORE, MD, 21224
- Phone: 301-327-0118
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Ben Auspitz | Director | Cambridge, MA |
| Joseph Amprey III | Director | Baltimore, MD |
| Joseph Amprey III | Executive Officer | Baltimore, MD |
| Jodi Jahic | Director | Baltimore, MD |
Other filings by this issuer (1)
More